Intake questionnaire

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Applying to Rapid City Medical Center, LLP · Rapid City, South Dakota

This location is no longer enrolling.

Other locations for this study may still be open.